Kent McDaniel
Psychiatry · Glen Allen, VANPI 1871640789
Payments from drug & device makers
Across 2,297 payments — averaging $930.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$588K
- Neurocrine Biosciences, Inc.$408K
- Johnson & Johnson$367K
- Alkermes, Inc.$358K
- Teva Pharmaceuticals USA, Inc.$230K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$160K
- plus $26K from 5 others
What the payments were for
- Consulting fees$45,5962%
- Speaking & faculty fees$1,893,97989%
- Travel & lodging$157,3737%
- Food & beverage$39,4162%
- Education$880%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 618 | $587,705 |
| Neurocrine Biosciences, Inc. | 372 | $408,319 |
| Johnson & Johnson | 419 | $367,009 |
| Alkermes, Inc. | 471 | $357,679 |
| Teva Pharmaceuticals USA, Inc. | 229 | $229,575 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 144 | $160,301 |
| E.r. Squibb & Sons, L.L.C. | 27 | $18,387 |
| Sunovion Pharmaceuticals Inc. | 13 | $7,208 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $131 |
| Gilead | 1 | $124 |
| AbbVie | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ARISTADA$826,746
- LYBALVI$495,769
- ABILIFY MAINTENA$451,193
- INGREZZA$403,040
- INVEGA SUSTENNA$357,599
- INVEGA TRINZA$356,422
- ARISTADA INITIO$206,686
- CAPLYTA$157,883
- ABILIFY ASIMTUFII$153,515
- REXULTI$130,115
- UZEDY$121,417
- Austedo XR$99,634
- VIVITROL$20,052
- COBENFY$17,831
- LATUDA$7,148
- AUSTEDO$5,903
- SPRAVATO$3,713
- INVEGA$125
- Epclusa$124
How this compares
$2,136,453 in reported general payments places this provider in the 95th percentile of 884 psychiatry providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega TrinzaPaliperidone Palmitate | 22 | $223,344 |
| IngrezzaValbenazine Tosylate | 14 | $112,626 |
| LybalviOlanzapine/Samidorphan Malate | 41 | $74,502 |
| Abilify MaintenaAripiprazole | 15 | $44,398 |
| RexultiBrexpiprazole | 26 | $30,095 |
| CaplytaLumateperone Tosylate | 12 | $20,938 |
| Clozapine | 233 | $11,661 |
| Olanzapine | 129 | $8,625 |
| Chlorpromazine Hcl | 13 | $6,484 |
| Aripiprazole | 33 | $1,790 |
| Fluphenazine Decanoate | 18 | $1,590 |
| Risperidone | 127 | $1,502 |
| Mirtazapine | 92 | $1,477 |
| Lurasidone Hcl | 22 | $1,361 |
| Perphenazine | 16 | $1,311 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Trinza | $367,009 | $223,34422 claims |
| Neurocrine Biosciences, Inc.Ingrezza | $408,319 | $112,62614 claims |
| Alkermes, Inc.Lybalvi | $357,679 | $74,50241 claims |
| Otsuka America Pharmaceutical, Inc.Abilify Maintena, Rexulti | $587,705 | $74,49341 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $160,301 | $20,93812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 884 psychiatry providers in Virginia.
Other psychiatry in Glen Allen
- Niku SinghFalls Church$2.5M
- David ScheidererRoanoke$2.4M
- Jasdeep MiglaniManassas$958K
- Frederick MoellerRichmond$678K
- David SpiegelNorfolk$565K
- Christopher van EyckStafford$392K
- Anita ClaytonCharlottesville$356K
- Anita KablingerRoanoke$333K
- William YetterVirginia Beach$312K
- Robert GardellaStaunton$201K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.